Insulet Recalls Omnipod Pods Due to Insulin Leakage Risk
Insulet has recalled certain Omnipod Pods due to a defect that may cause insulin leakage.
Therapeutic Area
Therapeutic area intelligence for Insulin Delivery with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.